SPY338.80-6.98 -2.02%
DIA276.69-6.65 -2.35%
IXIC11,362.93-185.35 -1.61%

Credit Suisse Maintains Outperform on Kura Oncology, Raises Price Target to $43

Credit Suisse analyst Martin Auster maintains Kura Oncology (NASDAQ:KURA) with a Outperform and raises the price target from $27 to $43.

· 10/08/2020 07:59
Credit Suisse analyst Martin Auster maintains Kura Oncology (NASDAQ:KURA) with a Outperform and raises the price target from $27 to $43.